1. Home
  2. OGN vs QLYS Comparison

OGN vs QLYS Comparison

Compare OGN & QLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OGN
  • QLYS
  • Stock Information
  • Founded
  • OGN 1923
  • QLYS 1999
  • Country
  • OGN United States
  • QLYS United States
  • Employees
  • OGN N/A
  • QLYS N/A
  • Industry
  • OGN Biotechnology: Pharmaceutical Preparations
  • QLYS Computer Software: Prepackaged Software
  • Sector
  • OGN Health Care
  • QLYS Technology
  • Exchange
  • OGN Nasdaq
  • QLYS Nasdaq
  • Market Cap
  • OGN 4.7B
  • QLYS 4.5B
  • IPO Year
  • OGN N/A
  • QLYS 2012
  • Fundamental
  • Price
  • OGN $14.89
  • QLYS $150.18
  • Analyst Decision
  • OGN Hold
  • QLYS Hold
  • Analyst Count
  • OGN 3
  • QLYS 18
  • Target Price
  • OGN $21.33
  • QLYS $154.19
  • AVG Volume (30 Days)
  • OGN 3.2M
  • QLYS 629.5K
  • Earning Date
  • OGN 10-31-2024
  • QLYS 11-05-2024
  • Dividend Yield
  • OGN 7.51%
  • QLYS N/A
  • EPS Growth
  • OGN 120.97
  • QLYS 22.85
  • EPS
  • OGN 5.04
  • QLYS 4.53
  • Revenue
  • OGN $6,409,000,000.00
  • QLYS $592,950,000.00
  • Revenue This Year
  • OGN $3.13
  • QLYS $11.15
  • Revenue Next Year
  • OGN $2.18
  • QLYS $7.65
  • P/E Ratio
  • OGN $2.95
  • QLYS $33.12
  • Revenue Growth
  • OGN 4.21
  • QLYS 9.66
  • 52 Week Low
  • OGN $10.84
  • QLYS $119.17
  • 52 Week High
  • OGN $23.10
  • QLYS $206.35
  • Technical
  • Relative Strength Index (RSI)
  • OGN 29.13
  • QLYS 63.00
  • Support Level
  • OGN $14.39
  • QLYS $140.31
  • Resistance Level
  • OGN $15.85
  • QLYS $155.93
  • Average True Range (ATR)
  • OGN 0.56
  • QLYS 5.83
  • MACD
  • OGN -0.08
  • QLYS 0.02
  • Stochastic Oscillator
  • OGN 13.76
  • QLYS 60.68

About OGN Organon & Co.

Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

About QLYS Qualys Inc.

Qualys is a cloud security and compliance solutions provider that helps businesses identify and manage their security risks and compliance requirements. The California-based company has more than 10,000 customers worldwide, the majority of which are small- and medium-size businesses. Qualys was founded in 1999 and went public in 2012.

Share on Social Networks: